Scientists test new liver pill: does it work better with food?
NCT ID NCT07334080
Summary
This early-stage study aims to understand how eating food affects different versions of an experimental drug called ECC4703, which is being developed for a serious liver disease. Researchers will give single doses to about 72 healthy adults to measure how the drug moves through the body when taken with and without food. The main goal is to gather safety data and decide which pill formulation works best for future testing in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMAX Clinical Research Pty Ltd
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact
Conditions
Explore the condition pages connected to this study.